Many people with hypothyroidism use these medications successfully
Krger noted that "According to recently presented database analyses by the respective manufacturers, each company's own drug appears to reduce cardiovascular risk much more effectively than the competitor's." He added, "However, our study found only small differences between tirzepatide and semaglutide in cardiovascular protection among populations at risk of adverse events, underscoring that both agents provide protective benefit and could be integrated into clinical cardiovascular practice." "We hope that our study will help clinicians better understand how these new medications work in clinical practice
The role of a balanced diet is paramount in managing regain weight that might occur after stopping the medication
"Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice"
With the brand new JDC Burst 1, GLP continues its success story with a significantly more powerful strobe/wash hybrid
These findings reinforce the view that obesity is a chronic, relapsing condition, and that ongoing treatment may be necessary to sustain the health benefits achieved with incretin-based therapies